机译:控制释放的vegfredox-responsive polydopamine纳米颗粒
Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, 134-140 W Woodruff Ave, Columbus, OH 43210 USA;
Ohio State Univ, Dept Biomed Engn, 1080 Carmack Rd, Columbus, OH 43210 USA;
Controlled Release Dosage Form; Nanoparticles; BevacizumabAngiogenesis InhibitorsPatient ComplianceAngiogenesis;
机译:The 46th Controlled Release Society Annual Meeting & Exposition 2019年7月21日~7月24日 Palacio de Congresos de Valencia,スペイン
机译:勘误:局部和玻璃体内施用阳离子纳米乳剂以将针对VEGF KDR受体的反义寡核苷酸递送至眼睛(Journal of Controlled Release(2010)145:3(297-305))
机译:对于靶向疫苗递送,向纳米的勘误要优于微米的情况[Journal of Control Release,144,(2010),117]
机译:Controlled Drug Release by Designed Crystallization Technology
机译:传统PI-Control,带解耦的PI-Control和动态矩阵控制的比较。
机译:使用抗血管内皮生长因子(anti-VEGF)治疗的视网膜疾病的真实数据–一种识别和表征数据源的系统方法
机译:microfluidic Device for Controllable Chemical Release via Field-actuated membrane Incorporating Nanoparticles
机译:Control Data Corporation CDC CYBER 73,NOs 1.4 Release Level 508 COBOL 5.3,Release Level 518